MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 227 filers reported holding MYRIAD GENETICS INC in Q3 2016. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $666,590 | -72.3% | 41,558 | -60.0% | 0.00% | -100.0% |
Q2 2023 | $2,408,194 | +53.5% | 103,891 | +53.9% | 0.00% | 0.0% |
Q1 2023 | $1,568,466 | +263.1% | 67,519 | +126.8% | 0.00% | – |
Q4 2022 | $432,021 | +10.2% | 29,774 | +44.8% | 0.00% | – |
Q3 2022 | $392,000 | -78.6% | 20,567 | -71.7% | 0.00% | – |
Q1 2022 | $1,832,000 | +214.2% | 72,714 | +244.6% | 0.00% | – |
Q4 2021 | $583,000 | -11.5% | 21,102 | +3.4% | 0.00% | – |
Q3 2021 | $659,000 | -57.5% | 20,400 | -59.8% | 0.00% | – |
Q2 2021 | $1,550,000 | +108.9% | 50,700 | +108.1% | 0.00% | – |
Q1 2021 | $742,000 | -59.8% | 24,366 | -73.9% | 0.00% | -100.0% |
Q4 2020 | $1,847,000 | +99.2% | 93,384 | +31.4% | 0.00% | – |
Q3 2020 | $927,000 | +5.2% | 71,054 | -8.7% | 0.00% | – |
Q2 2020 | $881,000 | -23.3% | 77,795 | +84.7% | 0.00% | -100.0% |
Q4 2019 | $1,148,000 | +91.7% | 42,129 | +101.5% | 0.00% | +100.0% |
Q3 2019 | $599,000 | +87.8% | 20,910 | +81.8% | 0.00% | 0.0% |
Q2 2019 | $319,000 | +4.2% | 11,500 | +11.0% | 0.00% | 0.0% |
Q1 2018 | $306,000 | -18.2% | 10,364 | -28.3% | 0.00% | 0.0% |
Q2 2017 | $374,000 | +29.4% | 14,458 | +3.1% | 0.00% | 0.0% |
Q3 2016 | $289,000 | -71.5% | 14,029 | -40.2% | 0.00% | -83.3% |
Q4 2015 | $1,013,000 | +111.5% | 23,461 | +83.7% | 0.01% | +100.0% |
Q3 2015 | $479,000 | +5.3% | 12,770 | -4.1% | 0.00% | -40.0% |
Q1 2014 | $455,000 | – | 13,318 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |